Aboleris Holdco
La probabilité de faillite calculée de Aboleris Holdco sur 12 mois est de 1,0% (faible). L'entreprise est active depuis 2023 et le Moniteur belge ne contient aucun signal d'insolvabilité ou d'avertissement. Aucun chiffre de comptes annuels traité n'est disponible ; cette conclusion repose uniquement sur les données du registre et du Moniteur belge.
| Active | 3 ans |
| Sites | 1 |
| Publications | 8 |
Estimation statistique fondée sur des sources publiques — pas un conseil de crédit ni une constatation. Comment calculons-nous cela ?
| Exercice | Type | Dépôt | Référence |
|---|---|---|---|
| 31-12-2024 | volledig | 06-05-2025 | 2025-00091730 |
| 31-12-2023 | volledig | 28-03-2024 | 2024-00052266 |
| NACE primaire | 72101 |
| Forme juridique | SA(014) |
| Date de constitution | 27-06-2023 |
| Status | Actif |
| Code postal | 6041 |
Parcelles liées à cette entreprise via ses adresses BCE (siège, unités d'établissement, succursales), croisées avec le plan parcellaire cadastral. Ceci montre où l'entreprise est active — pas un registre de propriété.
| Parcelle (capakey) | Région | Superficie | Bâtiments | Hauteur / ét. |
|---|---|---|---|---|
| 52028B0323/00M003 | Wallonie | 8 679 m² | 1 · 791 m² | 18,8 m · 5 ét. |
Une seule chronologie de tout ce qui est arrivé à cette entreprise — publications, événements d'insolvabilité et de cycle de vie, changements administratifs et comptes annuels déposés.
16-09-2025 3 administrateurs nommés
- Laurent Verhavert — Directeur
- Simon Bizimana — Directeur
- Strelia — Directeur
Détails techniques
{
"events": [
{
"kind": "rep_rotation",
"role": "directeur",
"person": {
"rrn": null,
"name": "Guillaume Heynen",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "Newton Biocapital Partners",
"address": null,
"country": null,
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Les administrateurs prennent acte du remplacement de Mr. Guillaume Heynen par Mr. Alain Parthoens comme repr\u00E9sentant permanent de l\u0027administrateur Newton Biocapital Partners.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": "Alain Parthoens",
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "rep_rotation",
"role": "directeur",
"person": {
"rrn": null,
"name": "Bibhash Mukhopadhyay",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "Sound Bioventures Management AB",
"address": null,
"country": null,
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Les administrateurs prennent acte du remplacement de Mr. Bibhash Mukhopadhyay par Mr. Casper Breum comme repr\u00E9sentant permanent de l\u0027administrateur Sound Bioventures Management A\u0412.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": "Casper Breum",
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "directeur",
"person": {
"rrn": null,
"name": "Laurent Verhavert",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Les administrateurs donnent procuration \u00E0 Laurent Verhavert, Simon Bizimana et tout autre avocat ou employ\u00E9 du cabinet Strelia ayant tous leurs bureaux situ\u00E9s rue de la R\u00E9gence 52, 1000 Bruxelles, chacun agissant individuellement et avec pouvoir de substitution, afin d\u0027accomplir toutes les formalit\u00E9",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "directeur",
"person": {
"rrn": null,
"name": "Simon Bizimana",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Les administrateurs donnent procuration \u00E0 Laurent Verhavert, Simon Bizimana et tout autre avocat ou employ\u00E9 du cabinet Strelia ayant tous leurs bureaux situ\u00E9s rue de la R\u00E9gence 52, 1000 Bruxelles, chacun agissant individuellement et avec pouvoir de substitution, afin d\u0027accomplir toutes les formalit\u00E9",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "directeur",
"person": null,
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "Strelia",
"address": "rue de la R\u00E9gence 52, 1000 Bruxelles",
"country": "BE",
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Les administrateurs donnent procuration \u00E0 Laurent Verhavert, Simon Bizimana et tout autre avocat ou employ\u00E9 du cabinet Strelia ayant tous leurs bureaux situ\u00E9s rue de la R\u00E9gence 52, 1000 Bruxelles, chacun agissant individuellement et avec pouvoir de substitution, afin d\u0027accomplir toutes les formalit\u00E9",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2025-09-16",
"filing_date": "2025-09-08",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "enig_aandeelhouder_schriftelijk",
"date": "2025-06-10",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0803.217.012",
"name_full": "ABOLERIS HOLDCO",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": "Strelia",
"person_name": null,
"org_rep_person_name": "Simon Bizimana",
"person_role_at_subject": null
},
"co_filed_documents": [],
"corrected_publication_numac": null
}14-04-2025 Augmentation de capital de 7.499.508 € à 30.988.985 €
- €23.489.477 → €30.988.985
Détails techniques
{
"events": [
{
"kind": "capital_increase",
"after_eur": 30988985.0,
"delta_eur": 7499508.0,
"before_eur": 23489477.0,
"share_emission": {
"agio_eur": 7499508.0,
"share_form": "no_nominal_value",
"share_class": "A",
"n_new_shares": 53188,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 141.0
},
"decrease_purpose": null,
"contribution_type": "numeraire",
"paid_up_delta_eur": 7499508.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Peter VAN MELKEBEKE",
"firm_city": null,
"firm_name": "BERQUIN NOTAIRES",
"office_city": "Bruxelles",
"is_associated": true
},
"act_meta": {
"language": "fr",
"pub_date": "2025-04-14",
"filing_date": "2025-04-10",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "assembl\u00E9e_generale_extraordinaire",
"act_date": "2025-04-02",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0803.217.012",
"name_full": "Aboleris Holdco",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"exp\u00E9dition du proc\u00E8s-verbal",
"liste de pr\u00E9sence",
"neuf procurations",
"le rapport de l\u0027organe d\u0027administration",
"le rapport du commissaire \u00E9valuant",
"le texte coordonn\u00E9 des statuts"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 20000,
"class_name": "Ordinaires",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 22500,
"class_name": "Seed A",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 1263,
"class_name": "Seed A\u0027",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 151866,
"class_name": "Pr\u00E9f\u00E9rentielles A",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
}
]
}05-12-2024 Publication au Moniteur belge — Divers
Détails techniques
{
"stage": null,
"notary": {
"name": "Kim Lagae",
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2024-12-05",
"filing_date": "2024-12-03",
"act_kind_objet": "DEMISSIONS, NOMINATIONS, DIVERS"
},
"decision": {
"body": "enig_aandeelhouder_schriftelijk",
"act_date": "2024-01-22",
"unanimous": true
},
"conversion": null,
"detected_kind": "other",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0803.217.012",
"name": "Aboleris Holdco",
"role": "other",
"address": "Rue Antoine de Saint-Exup\u00E9ry 14, 6041 Charleroi",
"is_foreign": false,
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": "0803.336.281",
"name": "Criteria Bio Ventures SICC SA",
"role": "contributor",
"address": null,
"is_foreign": true,
"legal_form": "SA",
"is_new_company": false,
"jurisdiction_country": "ES"
},
{
"kbo": null,
"name": "Sound Bioventures Management AB",
"role": "contributor",
"address": null,
"is_foreign": true,
"legal_form": "AB",
"is_new_company": false,
"jurisdiction_country": "SE"
},
{
"kbo": null,
"name": "Biotech corporate dev",
"role": "contributor",
"address": "35 quai Jean Pierre Fougerat, 44220 Coueron",
"is_foreign": true,
"legal_form": null,
"is_new_company": false,
"jurisdiction_country": "FR"
}
],
"exchange_ratio": null,
"legal_articles": [
"7:133"
],
"is_cross_border": true,
"is_silent_merger": false,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": null,
"real_estate_included": false,
"patrimony_description": null,
"equity_transferred_eur": null,
"accounting_effective_date": null
},
"subject_company": {
"kbo": "0803.217.012",
"name_full": "Aboleris Holdco",
"legal_form": "Soci\u00E9t\u00E9 anonyme"
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null
},
"summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale a pris acte de la d\u00E9mission de deux administrateurs et a nomm\u00E9 trois nouveaux administrateurs, dont deux soci\u00E9t\u00E9s \u00E9trang\u00E8res et une soci\u00E9t\u00E9 fran\u00E7aise, pour une dur\u00E9e de six ans.",
"co_filed_documents": [
"une copie des d\u00E9cisions \u00E9crites"
],
"detected_real_type": "other",
"referenced_correction": null,
"should_reroute_to_category": "director_changes"
}05-12-2024 3 administrateurs nommés, 2 démissionnaires
- Pablo Cironi López — Gedelegeerd bestuurder
- Bibhash Mukhopadhyay — Gedelegeerd bestuurder
- Frédéric Legros — Gedelegeerd bestuurder
- Pablo Cironi López — Gedelegeerd bestuurder
- Bibhash Mukhopadhyay — Gedelegeerd bestuurder
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "administrateur_d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Pablo Cironi L\u00F3pez",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale prend acte de la d\u00E9mission de Monsieur Pablo Cironi L\u00F3pez et Monsieur Bibhash Mukhopadhyay en tant qu\u2019administrateurs de la Soci\u00E9t\u00E9.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_out",
"role": "administrateur_d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Bibhash Mukhopadhyay",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale prend acte de la d\u00E9mission de Monsieur Pablo Cironi L\u00F3pez et Monsieur Bibhash Mukhopadhyay en tant qu\u2019administrateurs de la Soci\u00E9t\u00E9.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "administrateur_d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Pablo Cironi L\u00F3pez",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": "0803.336.281",
"name": "Criteria Bio Ventures SICC SA",
"address": null,
"country": "ES",
"legal_form": "SA"
},
"statutory": null,
"compensated": false,
"effective_date": null,
"evidence_quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de nommer en qualit\u00E9 d\u2019administrateurs de la Soci\u00E9t\u00E9, pour une dur\u00E9e de six (6) ans : Criteria Bio Ventures SICC SA",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "6"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "administrateur_d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Bibhash Mukhopadhyay",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "Sound Bioventures Management AB",
"address": null,
"country": "SE",
"legal_form": "AB"
},
"statutory": null,
"compensated": false,
"effective_date": null,
"evidence_quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de nommer en qualit\u00E9 d\u2019administrateurs de la Soci\u00E9t\u00E9, pour une dur\u00E9e de six (6) ans : Sound Bioventures Management AB",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "6"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "administrateur_d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Fr\u00E9d\u00E9ric Legros",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "Biotech corporate dev",
"address": "35 quai Jean Pierre Fougerat, 44220 Coueron",
"country": "FR",
"legal_form": null
},
"statutory": null,
"compensated": true,
"effective_date": null,
"evidence_quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de nommer en qualit\u00E9 d\u2019administrateurs de la Soci\u00E9t\u00E9, pour une dur\u00E9e de six (6) ans : Biotech corporate dev",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "rep_rotation",
"role": "vaste_vertegenwoordiger",
"person": {
"rrn": null,
"name": "Pablo Cironi L\u00F3pez",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": "0803.336.281",
"name": "Criteria Bio Ventures SICC SA",
"address": null,
"country": "ES",
"legal_form": "SA"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "repr\u00E9sent\u00E9e par Monsieur Pablo Cironi L\u00F3pez en tant que repr\u00E9sentant permanent",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "rep_rotation",
"role": "vaste_vertegenwoordiger",
"person": {
"rrn": null,
"name": "Bibhash Mukhopadhyay",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "Sound Bioventures Management AB",
"address": null,
"country": "SE",
"legal_form": "AB"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "repr\u00E9sent\u00E9e par Monsieur Bibhash Mukhopadhyay en tant que repr\u00E9sentant permanent",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "rep_rotation",
"role": "vaste_vertegenwoordiger",
"person": {
"rrn": null,
"name": "Fr\u00E9d\u00E9ric Legros",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "Biotech corporate dev",
"address": "35 quai Jean Pierre Fougerat, 44220 Coueron",
"country": "FR",
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "repr\u00E9sent\u00E9e par Monsieur Fr\u00E9d\u00E9ric Legros en tant que repr\u00E9sentant permanent",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": "Kim Lagae",
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2024-12-05",
"filing_date": "2024-12-03",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "enig_aandeelhouder_schriftelijk",
"date": "2024-01-22",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0803.217.012",
"name_full": "Aboleris Holdco",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Kim Lagae",
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"une copie des d\u00E9cisions \u00E9crites"
],
"corrected_publication_numac": null
}25-04-2024 Augmentation de capital de 7.900.000 € à 23.489.477 €
- €15.589.477 → €23.489.477
- Inbreng in geld · Apport en numéraire
Détails techniques
{
"events": [
{
"kind": "capital_increase",
"after_eur": 23489477.0,
"delta_eur": 7900000.0,
"before_eur": 15589477.0,
"share_emission": {
"agio_eur": null,
"share_form": "nominal",
"share_class": "A",
"n_new_shares": 63198,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 7900000.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Kim LAGAE",
"firm_city": null,
"firm_name": null,
"office_city": "Bruxelles",
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2024-04-25",
"filing_date": "2024-04-23",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "assembl\u00E9e g\u00E9n\u00E9rale extraor-dinaire des actionnaires",
"act_date": "2024-04-17",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0803.217.012",
"name_full": "Aboleris Holdco",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition conforme de l\u0027acte",
"procurations",
"Rapport sp\u00E9cial du conseil d\u0027administration",
"Rapport sp\u00E9cial du commissaire",
"coordination des statuts"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 20000,
"class_name": "Ordinaires",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 22500,
"class_name": "Seed A",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 1263,
"class_name": "Seed A\u0027",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 98678,
"class_name": "Pr\u00E9f\u00E9rentielles A",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
}
]
}16-04-2024 Transfert du siège social vers Gosselies
- rue Antoine Saint-Exupéry 14 à 6041 Gosselies
Détails techniques
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "siege_social",
"new_address": {
"raw": "rue Antoine Saint-Exup\u00E9ry 14 \u00E0 6041 Gosselies",
"city": "Gosselies",
"region": "waals_gewest",
"street": "Antoine Saint-Exup\u00E9ry",
"country": "BE",
"postcode": "6041",
"box_number": null,
"street_number": "14",
"locality_suffix": null
},
"old_address": null,
"effective_date": "2024-05-01",
"evidence_quote": "",
"region_changed": false,
"is_statute_change": true,
"nationality_change": false,
"old_address_source": "missing",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "future",
"statutaire_vs_werkelijke": "statutaire",
"linguistic_region_changed": false,
"court_jurisdiction_changed": false,
"effective_date_is_approximate": false
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2024-04-16",
"filing_date": null,
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "algemene_vergadering",
"date": "2024-04-05",
"unanimous": null
},
"subject_company": {
"kbo": "0803.217.012",
"name_full": "ABOLERIS HOLDO",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": "BDO R\u00E9viseurs d\u0027Entreprises SRL",
"person_name": null,
"org_rep_person_name": "S\u00E9bastien Jaspar",
"person_role_at_subject": null
},
"co_filed_documents": [
"Bijlagen bij bij het het Belgisch Staatsblad",
"Annexes du Moniteur belge"
]
}20-07-2023 Augmentation de capital de 6.150.000 € à 15.589.477 €
- €9.439.477 → €15.589.477
- Inbreng in geld · Apport en numéraire
- 2 kapitaalbewegingen in deze akte
Détails techniques
{
"events": [
{
"kind": "eenhoofdigheid_declaration",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "statutory_reserve_release",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 9439477.0,
"delta_eur": 720000.0,
"before_eur": 8719477.0,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Newton Biocapital I",
"share_class": "A",
"liberation_pct": 100.0,
"contribution_kind": "schuldvordering",
"n_shares_subscribed": 2880,
"contribution_amount_eur": 720000.0
}
],
"share_emission": {
"agio_eur": null,
"share_form": "pair_comptable",
"share_class": "A",
"n_new_shares": 2880,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": 720000.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 15589477.0,
"delta_eur": 6150000.0,
"before_eur": 9439477.0,
"share_emission": {
"agio_eur": null,
"share_form": "pair_comptable",
"share_class": "A",
"n_new_shares": 24600,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 250.0
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 6150000.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Kim LAGAE",
"firm_city": null,
"firm_name": null,
"office_city": "Bruxelles",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2023-07-20",
"filing_date": "2023-07-18",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "assembl\u00E9e g\u00E9n\u00E9rale extraordinaire",
"act_date": "2023-07-10",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": {
"waived": false,
"firm_kbo": null,
"firm_name": "CdP NB\u0026C\u00B0 SRL, R\u00E9viseurs d\u2019entreprises",
"ibr_number": null,
"mission_type": "apport_nature",
"individual_name": "Jean Nicolet"
},
"subject_company": {
"kbo": "0803.217.012",
"name_full": "Aboleris Holdco",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition",
"rapports",
"coordination des statuts"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 27440,
"class_name": "Actions Pr\u00E9f\u00E9rentielles A",
"capital_share_eur": 9439477.0,
"voting_rights_per_share": 1.0
}
]
}12-07-2023 Augmentation de capital de 5.519.264,03 € à 8.719.477 €
- €3.200.212,97 → €8.719.477
Détails techniques
{
"events": [
{
"kind": "capital_increase",
"after_eur": 8719477.0,
"delta_eur": 5519264.03,
"before_eur": 3200212.97,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Investisseurs d\u2019actions de la soci\u00E9t\u00E9 Aboleris Pharma",
"share_class": null,
"liberation_pct": 100.0,
"contribution_kind": "natura",
"n_shares_subscribed": 32765,
"contribution_amount_eur": 5519264.03
}
],
"share_emission": {
"agio_eur": null,
"share_form": "pair_comptable",
"share_class": null,
"n_new_shares": 32765,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "apport_nature",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Kim LAGAE",
"firm_city": null,
"firm_name": null,
"office_city": "Bruxelles",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2023-07-12",
"filing_date": "2023-07-10",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "assembl\u00E9e_generale_extraordinaire",
"act_date": null,
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": {
"waived": false,
"firm_kbo": null,
"firm_name": "CDP NICOLET, BERTRAND \u0026 C\u00B0 R\u00E9viseurs d\u2019entreprises SRL",
"ibr_number": null,
"mission_type": "apport_nature",
"individual_name": "Jean NICOLET"
},
"subject_company": {
"kbo": "0803.217.012",
"name_full": "Aboleris Holdco",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"exp\u00E9dition conforme de l\u2019acte",
"procurations",
"coordination des statuts"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 51763,
"class_name": "Gewone Aandelen",
"capital_share_eur": 8719477.0,
"voting_rights_per_share": 1.0
}
]
}Générez une note structurée et factuelle à partir de tous les signaux de ce dossier : risque, santé financière, structure de propriété, mandats et comparaison sectorielle.
| Dénomination légaleFR | Aboleris Holdco |